These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

519 related items for PubMed ID: 20207347

  • 21. Varenicline in prevention of relapse to smoking: effect of quit pattern on response to extended treatment.
    Hajek P, Tønnesen P, Arteaga C, Russ C, Tonstad S.
    Addiction; 2009 Sep; 104(9):1597-602. PubMed ID: 19686530
    [Abstract] [Full Text] [Related]

  • 22. Human abuse liability of the smoking cessation drug varenicline in smokers and nonsmokers.
    McColl SL, Burstein AH, Reeves KR, Billing CB, Stolar M, Sellers EM.
    Clin Pharmacol Ther; 2008 Apr; 83(4):607-14. PubMed ID: 18288085
    [Abstract] [Full Text] [Related]

  • 23. Brain metabolite concentrations and neurocognition during short-term recovery from alcohol dependence: Preliminary evidence of the effects of concurrent chronic cigarette smoking.
    Durazzo TC, Gazdzinski S, Rothlind JC, Banys P, Meyerhoff DJ.
    Alcohol Clin Exp Res; 2006 Mar; 30(3):539-51. PubMed ID: 16499496
    [Abstract] [Full Text] [Related]

  • 24. Down-regulation of amygdala and insula functional circuits by varenicline and nicotine in abstinent cigarette smokers.
    Sutherland MT, Carroll AJ, Salmeron BJ, Ross TJ, Hong LE, Stein EA.
    Biol Psychiatry; 2013 Oct 01; 74(7):538-46. PubMed ID: 23506999
    [Abstract] [Full Text] [Related]

  • 25. Effects of varenicline in adult smokers: a multinational, 24-week, randomized, double-blind, placebo-controlled study.
    Bolliger CT, Issa JS, Posadas-Valay R, Safwat T, Abreu P, Correia EA, Park PW, Chopra P.
    Clin Ther; 2011 Apr 01; 33(4):465-77. PubMed ID: 21635992
    [Abstract] [Full Text] [Related]

  • 26. Working memory-related neural activity predicts future smoking relapse.
    Loughead J, Wileyto EP, Ruparel K, Falcone M, Hopson R, Gur R, Lerman C.
    Neuropsychopharmacology; 2015 May 01; 40(6):1311-20. PubMed ID: 25469682
    [Abstract] [Full Text] [Related]

  • 27. Males and females differ in brain activation during cognitive tasks.
    Bell EC, Willson MC, Wilman AH, Dave S, Silverstone PH.
    Neuroimage; 2006 Apr 01; 30(2):529-38. PubMed ID: 16260156
    [Abstract] [Full Text] [Related]

  • 28. Effects of varenicline on smoking cue–triggered neural and craving responses.
    Franklin T, Wang Z, Suh JJ, Hazan R, Cruz J, Li Y, Goldman M, Detre JA, O'Brien CP, Childress AR.
    Arch Gen Psychiatry; 2011 May 01; 68(5):516-26. PubMed ID: 21199958
    [Abstract] [Full Text] [Related]

  • 29. Cholinergic agonism alters cognitive processing and enhances brain functional connectivity in patients with multiple sclerosis.
    Cader S, Palace J, Matthews PM.
    J Psychopharmacol; 2009 Aug 01; 23(6):686-96. PubMed ID: 18635705
    [Abstract] [Full Text] [Related]

  • 30. Effects of dextroamphetamine on cognitive performance and cortical activation.
    Mattay VS, Callicott JH, Bertolino A, Heaton I, Frank JA, Coppola R, Berman KF, Goldberg TE, Weinberger DR.
    Neuroimage; 2000 Sep 01; 12(3):268-75. PubMed ID: 10944409
    [Abstract] [Full Text] [Related]

  • 31. Use of varenicline for 4 weeks before quitting smoking: decrease in ad lib smoking and increase in smoking cessation rates.
    Hajek P, McRobbie HJ, Myers KE, Stapleton J, Dhanji AR.
    Arch Intern Med; 2011 Apr 25; 171(8):770-7. PubMed ID: 21518946
    [Abstract] [Full Text] [Related]

  • 32. Working memory deficits predict short-term smoking resumption following brief abstinence.
    Patterson F, Jepson C, Loughead J, Perkins K, Strasser AA, Siegel S, Frey J, Gur R, Lerman C.
    Drug Alcohol Depend; 2010 Jan 01; 106(1):61-4. PubMed ID: 19733449
    [Abstract] [Full Text] [Related]

  • 33. The neurobiological basis for partial agonist treatment of nicotine dependence: varenicline.
    Foulds J.
    Int J Clin Pract; 2006 May 01; 60(5):571-6. PubMed ID: 16700857
    [Abstract] [Full Text] [Related]

  • 34. Neuroimaging of marijuana smokers during inhibitory processing: a pilot investigation.
    Gruber SA, Yurgelun-Todd DA.
    Brain Res Cogn Brain Res; 2005 Apr 01; 23(1):107-18. PubMed ID: 15795138
    [Abstract] [Full Text] [Related]

  • 35. Acute caffeine administration impact on working memory-related brain activation and functional connectivity in the elderly: a BOLD and perfusion MRI study.
    Haller S, Rodriguez C, Moser D, Toma S, Hofmeister J, Sinanaj I, Van De Ville D, Giannakopoulos P, Lovblad KO.
    Neuroscience; 2013 Oct 10; 250():364-71. PubMed ID: 23876323
    [Abstract] [Full Text] [Related]

  • 36. Effects of varenicline and bupropion on cognitive processes among nicotine-deprived smokers.
    Ashare RL, McKee SA.
    Exp Clin Psychopharmacol; 2012 Feb 10; 20(1):63-70. PubMed ID: 21942262
    [Abstract] [Full Text] [Related]

  • 37. The effect of varenicline on heart rate variability in healthy smokers and nonsmokers.
    Ari H, Celiloğlu N, Ari S, Coşar S, Doganay K, Bozat T.
    Auton Neurosci; 2011 Oct 28; 164(1-2):82-6. PubMed ID: 21664880
    [Abstract] [Full Text] [Related]

  • 38. Pharmacokinetics, safety, and tolerability after single and multiple oral doses of varenicline in elderly smokers.
    Burstein AH, Fullerton T, Clark DJ, Faessel HM.
    J Clin Pharmacol; 2006 Nov 28; 46(11):1234-40. PubMed ID: 17050788
    [Abstract] [Full Text] [Related]

  • 39. Effect of varenicline on aspects of inhibitory control in smokers.
    Austin AJ, Duka T, Rusted J, Jackson A.
    Psychopharmacology (Berl); 2014 Sep 28; 231(18):3771-85. PubMed ID: 24652107
    [Abstract] [Full Text] [Related]

  • 40. Brain activity in cigarette smokers performing a working memory task: effect of smoking abstinence.
    Xu J, Mendrek A, Cohen MS, Monterosso J, Rodriguez P, Simon SL, Brody A, Jarvik M, Domier CP, Olmstead R, Ernst M, London ED.
    Biol Psychiatry; 2005 Jul 15; 58(2):143-50. PubMed ID: 16038685
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.